Homelessness, drug abuse and dirt bike riders causing havoc are some of the key concerns Northland business leaders raised ...

Icon's balance sheet is sound, with its revenue cyclicality and operating leverage each possessing a medium rating. Icon has historically maintained a fairly conservative balance sheet, and it ended ...

Our partnership with federal agencies like the FBI is a key part of our strategy to disrupt drug trafficking operations.' ...

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

The number of people suffering from osteoarthritis is expected to top 1 billion by 2050. The biggest risk factor for the ...

CEO Brian Goff highlighted Agios’ mission of delivering transformative therapies for rare diseases and emphasized the strong financial position with $1.4 billion in cash, enabling independent funding ...

Look out for the key nutrients. When in doubt, try to prioritize foods with fiber and complex carbs, protein, and healthy ...

LLY has delivered impressive returns of 15% year-to-date, outperforming the S&P 500’s 5% decline during the same period. This ...

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

Numerous studies have suggested the cultivation of cells derived from intestinal organoids as two-dimensional (2D) monolayers ...

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

Trump-era crackdowns are forcing gangs like Tren de Aragua to flee the U.S. through the Northern border and exploit Canada’s ...